Delek US Holdings Inc (DK) concluded trading on Thursday at a closing price of $19.66, with 3.23 million shares of worth about $63.59 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 5.36% during that period and on May 22, 2025 the price saw a gain of about 9.77%. Currently the company’s common shares owned by public are about 60.63M shares, out of which, 58.99M shares are available for trading.
Stock saw a price change of 5.93% in past 5 days and over the past one month there was a price change of 49.73%. Year-to-date (YTD), DK shares are showing a performance of 6.27% which decreased to -30.63% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $11.02 but also hit the highest price of $28.16 during that period. The average intraday trading volume for Delek US Holdings Inc shares is 1.77 million. The stock is currently trading 24.17% above its 20-day simple moving average (SMA20), while that difference is up 31.99% for SMA50 and it goes to 12.27% higher than SMA200.
Delek US Holdings Inc (NYSE: DK) currently have 60.63M outstanding shares and institutions hold larger chunk of about 113.63% of that.
The stock has a current market capitalization of $1.19B and its 3Y-monthly beta is at 0.88. It has posted earnings per share of -$12.65 in the same period. It has Quick Ratio of 0.53 while making debt-to-equity ratio of 20.14. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for DK, volatility over the week remained 5.76% while standing at 3.71% over the month.
Stock’s fiscal year EPS is expected to rise by 6.95% while it is estimated to increase by 57.06% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Mizuho on May 13, 2025 offering an Outperform rating for the stock and assigned a target price of $23 to it. On October 17, 2024, BofA Securities Resumed their recommendations, while on September 16, 2024, Mizuho Upgrade their ratings for the stock with a price target of $26. Stock get a Neutral rating from JP Morgan on September 10, 2024.
